ENG

  • Zhen LI

    Equity Partner / Beijing

  • Tel +86-10-5087-2956

    Email lizhenbj@zhonglun.com

  • Practices

    Chinese Mainland Capital Markets, Investment/M&A & Corporate Governance, Private Equity & Investment Funds

CV

Zhen LI

Zhen Li specializes in Chinese domestic IPO, refinancing of listed companies, asset restructuring of listed companies, M&A, fundraising and investment of private equity funds, and other fields. She also has extensive experience in the restructuring of state-owned enterprises into mixed-ownership enterprises, investment and financing of military enterprises, and ESOPs for state-owned enterprises and pre-IPO companies.
Zhen Li is also astute in dealing with legal matters related to the military industry, pharmaceuticals, healthcare and life sciences, integrated semiconductor, new materials, and the internet industry.

Representative Matters

Listing

  • Advised CETC Lantian Technology Co., Ltd. (688818.SH) on its IPO and STAR Market listing

  • Advised Guizhou Zhenhua Fengguang Semiconductor Co., Ltd. (688439.SH) on its IPO and STAR Market listing

  • Advised Beijing Tongyizhong New Material Technology Co., Ltd. (688722.SH) on its IPO and STAR Market listing

  • Advised Allgens Medical Technology Co., Ltd. (688613.SH) on its IPO and STAR Market listing

  • Advised Beijing Hengyu Datacom Aviation Equipment co., Ltd (300965.SZ) on its IPO and ChiNext listing

  • Advised Beijing Quanshi World Online Network Information Co., Ltd. (002995.SZ) on its IPO and main board listing

  • Ms. Li also participated in the initial public offering of Shandong Publishing & Media Co., Ltd. (601019.SH) and its listing on the Main Board of the Shanghai Stock Exchange, Shaanxi Coal Industry Company Limited (601225.SH) and its listing on the Main Board of the Shanghai Stock Exchange, Jinduicheng Molybdenum Company Limited (601958.SH), and other domestic IPOs a number of companies. 


M&A, Refinancing, and Restructuring of Listed Companies

Ms. Li, as the responsible partner or lead lawyer, has participated in the following projects:

  • Advised PetroChina Company Limited (601857.SH) on the restructuring of its domestic pipeline business and its investment in national pipeline projects

  • Advised Beijing Tongyizhong New Material Technology Co., Ltd. (688722.SH) on its acquiring control of X-FIPER New Material Co., Ltd.

  • Advised Beijing Tongyizhong New Material Technology Co., Ltd. (688722.SH) on its acquiring control of Yancheng Youhebo New Materials Co., Ltd.

  • Advised Chengdu Screen Micro-Electronic Co., Ltd.(688053.SH) on its acquiring control of Shaanxi Haice Electronic Technology Service Co., Ltd.

  • Advised Xi'an Triangle Defense Co.,Ltd. (300775.SZ) on its non-public offering

  • Advised China Nuclear Power (601985.SH) on its public offering of convertible bonds

  • Advised BAOJI TITANIUM INDUSTRY CO., LTD. (600456.SH) on its public offering of corporate bonds

  • Advised Dagang Holding Group Co.,Ltd. (300103.SZ) on its material asset restructuring and related transactions 

  • Advised China Railway (601390.SH) on its non-public offering

  • Advised BBMG Corporation (601992.SH) on its acquiring Jidong Development Group Co.,Ltd., and indirect acquisition of BBMG JIDONG CEMENT GROUP CO.,LTD (000401.SZ)

  • Advised Sinopec (600028.SH) on its public offering of convertible bonds and restructuring of its overseas subsidiary

  • Advised Shaanxi Fenghuo Electronics Co., Ltd. (000561.SZ) on its material asset disposal and purchase of assets by issuing shares 

  • Advised SHAANXI INTERNATIONAL TRUST Co.,Ltd. (000563.SZ) on its material asset disposal and related transactions, involving restructuring and refinancing of a number of listed companies

  • Advised Hong Kong Cheung Kong Industries and Hutchison Whampoa on their merger, restructuring, split, and Hong Kong listing


NEEQ Listing/Beijing Stock Exchange

Ms. Li, as the responsible partner or lead lawyer, has participated in the following projects:

  • Advised Jiangsu Feiyu Pharmaceutical Technology Co., Ltd. (874410) on its NEEQ listing and getting included in NEEQ innovation layer

  • Advised Beijing HuaTeng Hightech Co., Ltd. (873721) on its NEEQ listing and getting included in NEEQ innovation layer

  • Advised Shenzhen Huoli Tian Hui Technology Co., Ltd. (871860) on its NEEQ listing

  • Advised Qingdao Yeecare Science And Technology Co., Ltd. (837667) on its NEEQ listing

  • Advised Henan Liquor Easy Trading Corporation (838883) on its NEEQ listing and subsequent private placement

  • Advised Beijing Yingguan Dental Technology Co., Ltd. (838197) on its NEEQ listing

  • Advised Silian Intelligence Technology Share Co.,Ltd. (430758) on its NEEQ listing


Private Equity Investment 

Ms. Li has acted for a number of domestic private equity funds and fund management companies concerning their investment. Notable clients include CITIC Jinshi Investment Company, National Military and Civilian Integration Industry Investment Fund Co., Ltd., SDIC Chuanghe National Emerging Industry Venture Capital Guiding Fund (L.P.), Military Civilian Integration Development Industry Investment Fund (LP), Shanghai Military Civil Integration Industry Equity Investment Fund Partnership(L.P.), Hubei Integrated Development Industry Investment Fund Partnership (L.P.), Hangzhou Chuanghe Selected Venture Capital Partnership(L.P.) , Jiangxi Jinggangshan Beiyuan Venture Capital Management Co., Ltd., Tianjin Phoenix Tree Private Equity Fund Management Co., Ltd., funds owned byChina Aerospace Science and Technology Corporation(CASC), funds owned by China Aerospace Science and Industry Corporation (CASIC), and Tsing Song Capital.


Military and Defense Industry Capital Operations and Financing

  • Advised Chinarocket Co., Ltd. (space launch services and payload system design) on its equity investment

  • Advised Beijing Future Navigation Technology Co., Ltd. (Beidou satellite low-orbit navigation enhancement system and satellite constellation) on its equity investment

  • Advised Beijing Marknum Technology Co.,Ltd. (big data analysis and applications in public safety) on its equity investment

  • Advised Chengdu Rongxing Technology Co., Ltd. (radio signal monitoring and information processing) on its equity investment

  • Advised Satpro M&C Tech Co.,Ltd. (satellite communication antennas for vehicles, ships, and aircraft) on its equity investment

  • Advised Tuowei Electronic Technology(Shanghai) Co., Ltd. (chip research and development for digital and RF chips) on its equity investment

  • Advised Changchun Tongshi Optoelectronic Technology Co., Ltd. (optoelectronic systems including dynamic base imaging, axis stabilization, and target aiming) on its equity investment

  • Advised Shenzhen Consys Science & Technology Co.,Ltd. (688788.SH)(electronic information equipment for communication and meteorological detection fields) on its equity investment

  • Advised on the subscription of the non-publicly issued shares in China Tungsten And Hightech Materials Co.,Ltd.(000657.SZ)(development of rare metals and deep processing products)

  • Advised on the subscription of the non-publicly issued shares in ComNav Technology Ltd. (688592.SH) (the first domestic enterprise fully mastering core technology for high-precision Beidou/GNSS receiver modules)

  • Advised Morningcore Holding Co., Ltd.(Morningcore is a leader in the field of industry communication terminal SoC chips)on its equity investment 

  • Medical/Biotech/Pharmaceutical/Life Sciences Industry

  • Advised Jiangsu Trulive Medtech Co., Ltd. (covering multiple interventional therapy areas such as heart valves, peripheral vessels, and coronary arteries) on its equity investment

  • Advised ArtSurgical Medical Technology (Suzhou) Co., Ltd. (A research-based medical robotics company that provides treatment solutions in medical aesthetics, oncology, and vascular intervention) on its equity investment

  • Advised Shanghai MicroPort CardioFlow MedTech Ltd.(02160.HK)(research, development, production, and sales of VitaFlow transcatheter aortic valve and delivery systems) on its Series B equity investment

  • Advised Shanghai Innostar Bio-Tech Co.,Ltd. (preclinical safety assessment research services for pharmaceutical institutions worldwide) on its equity investment

  • Advised Shanghai Allist Pharmaceuticals Co., Ltd.(688578.SH)(innovative drug development and production for hypertension, oncology, diabetes, etc.) on its equity investment

  • Advised Shanghai Aohua Photoelectricity Endoscope Co., Ltd.(688212.SH)(medical endoscopes and related products) on its equity investment 

  • Advised Beijing-Geneplus Technology Co., Ltd. (gene therapy) on its equity investment

  • Advised Beijing Anlong Biopharmaceutical Co., Ltd. (genetic testing) on its equity investment

  • Advised Shanghai Huihe Medical Technology Co., Ltd. (tricuspid valve repair products for cardiac applications) on its equity investment

  • Advised Jiasite Huajian Medical Equipment(Tianjin)Co., Ltd. (orthopedic implant products) on its equity investment

  • Advised Sunvou Medical Electronics Co., Ltd.  (breath-based molecular diagnostic biosensor medical electronic products) on its equity investment

  • Advised Cangzhou Four Stars Glass Co., Ltd. (medical neutral borosilicate glass tubing, oral glass bottles, and anatomical bottles) on its equity investment

  • Advised Hec Pharma Co., Ltd. (active pharmaceutical ingredients) and Ruyuan Hec Pharm Co., Ltd. (active pharmaceutical ingredients) on its equity investment

  • Advised Beijing Kangdehong Medical Industry Technology Co., Ltd. and Beijing Yingchuangbaili Technology Development Co., Ltd. (sales of large-scale medical equipment in the radiological field, medical consumables, rental of medical equipment, and equipment management and maintenance services) on its equity investment


ESOP

Ms. Li has advised clients on the design and development of employee equity incentive programs and contributed to their successful implementation, including

  • State-Owned Enterprise ESOPs: proposed pre-IPO equity incentives for CETC Lantian Technology Co., Ltd. (688818.SH), Tongyi Zhongxin (688722.SH), Zhenhua Fengguang (688439.SH), Financial Street Property Co., Ltd. (01502.HK), Morningcore Holding Co., Ltd., Shaanxi Huajing Micro-Electronic Stock Co., Ltd., Tianshui Tianguang Semiconductor Co., Ltd..

  • Private Enterprise ESOPs: proposed pre-IPO equity and option incentives for Allgens Medical (688613.SH), Quanshi Tiandi Online Network Information  (002995.SZ), Longteng Semiconductor Co., Ltd, Jinzhou Liaojing Electronic Technology Co., Ltd., Jiangsu Feiyu Pharmaceutical Technology Co., Ltd., Vivolight, and dozens of other companies.

  • Listed Company ESOPs: proposed employee restricted stock incentives after its IPO for Jiangxi Fushine Pharmaceutical Co., Ltd. (300497.SZ), Allgens Medical (688613.SH), and Xi'an Triangle Defense Co.,Ltd. (300775.SZ).


Retainer-based Services and Compliance

Ms. Li served and is serving as retainer-based counsel and compliance counsel for many companies, including:

  • CETC Lantian Technology Co., Ltd. (688818.SH),

  • Zhenhua Fengguang (688439.SH),

  • Allgens Medical (688613.SH),

  • Tongyi Zhongxin (688722.SH),

  • Jiangxi Fushine Pharmaceutical Co., Ltd. (300497.SZ),

  • Ruijie Networks Co., Ltd. (301165.SZ),

  • Shenzhen Vivolight Medical Device & Technology Co.,Ltd., 

  • Shaanxi Huajing Micro-Electronic Stock Co., Ltd., 

  • Jiangxi Tianyi Aviation Equipment Co., Ltd., 

  • ArtSurgical Medical Technology (Suzhou) Co., Ltd. 

  • Bar Admissions/Professional Qualifications

    PRC Bar, 2010

  • Education

    LL.M., China University of Political Science and Law
    LL.B., Northwest University of Political Science and Law

  • Professional Experience

    Equity partner and non-equity partner, Zhong Lun Law Firm
    Equity partner and non-equity partner, Guan Tao Law Firm

  • Languages

    Chinese
    English